Same Indication

Irbesartan vs Pembrolizumab

Irbesartan vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Irbesartan and Pembrolizumab.

Mechanism of Action

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Irbesartan β€” 11-15 hours; Pembrolizumab β€” 26 days.

Chemical Properties

Molecular Formula: Irbesartan β€” C25H28N6O.

Molecular Weight: Irbesartan β€” 428.5320 g/mol.

Type: Irbesartan β€” Small molecule; Pembrolizumab β€” Antibody.